Purchase Short-Term Access

Periodic PSA-based screening in men 55 to 69 years of age reduced prostate cancer mortality

Richard M. Hoffman, MD, MPH

Annals of Internal Medicine 2012;157:JC1-4. doi:10.7326/0003-4819-157-2-201207170-02004

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)